Silencing of IFITM2 in gastric cancer cells decreased cell proliferation, migration, and metastasis, while IFITM2 depletion in a mouse model resulted in dramatic decreases in tumor size [75]. The gene discussed is IFITM2; the disease is gastric cancer.